Dr. Reddy's Laboratories Limited (ADR) share price logo

Dr. Reddy's Laboratories Limited (ADR)

NASDAQ: RDY

Mid Cap

$12.09

+0.24

(+2.03%)

Live

as on

Dr. Reddy's Laboratories Limited (ADR) Stock Performance

as on August 4, 2026 at 1:13 am IST

  • Day's Low

    Day's High

    $11.97
    $12.14
    downward going graph

    0.99%

    Downside

    0.41%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $11.36
    $15.67
    downward going graph

    6.04%

    Downside

    29.61%

    Upside

    downward going graph

Dr. Reddy's Laboratories Limited (ADR) share price movements today

Previous Close
$11.85
Open
$11.97
Volume
418.1K
Day's Low - High
$11.97 - $12.14
52 Week Low - High
$11.36 - $15.67

Dr. Reddy's Laboratories Limited (ADR) Historical Returns

1 Month Return
-17.59 %
3 Month Return
-13.63 %
1 Year Return
-14.99 %
3 Year Return
-14.02 %
5 Year Return
-6.38 %

Dr. Reddy's Laboratories Limited (ADR) Stock Fundamentals & Key Indicators

Check Dr. Reddy's Laboratories Limited (ADR) market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$9.9B

EPS (TTM)

56.33

Dividend Yield

0.70%

Quarterly Earnings Growth YOY

-0.69%

PE Ratio (TTM)

28.9

Industry PE ratio

25.72

PEG Ratio

1.5774

EBITDA

54.7B

Revenue (TTM)

331.2B

Profit Margin

10.00%

Return On Equity TTM

8.84%

Dr. Reddy's Laboratories Limited (ADR) Stock Valuation

Track how Dr. Reddy's Laboratories Limited (ADR) P/E has moved over time to understand its valuation trends.

Dr. Reddy's Laboratories Limited (ADR) in the last 5 years

  • Overview

  • Trends

Lowest (0.20x)

March 31, 2025

Industry (25.72x)

August 3, 2026

Today (28.90x)

August 3, 2026

Highest (32.13x)

June 30, 2026

LowHigh

Today’s Price to Earnings Ratio: 28.90x

Dr. Reddy's Laboratories Limited (ADR) vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Dr. Reddy's Laboratories Limited (ADR) with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Dr. Reddy's Laboratories Limited (ADR) image
Dr. Reddy's Laboratories Limited (ADR)
BUY$9.9B-6.38%28.910.00%0.7000000000000001%
United Therapeutics Corporation image
United Therapeutics Corporation
BUY$25.8B186.57%19.1240.62%NA
Viatris Inc. image
Viatris Inc.
HOLD$20.4B23.75%NA-2.04%2.7%
Haleon plc (ADR) image
Haleon plc (ADR)
BUY$43.5BNA20.5614.55%1.96%
ZOETIS INC. image
ZOETIS INC.
BUY$31.9B-62.13%12.6728.04%2.67%
See all

Stock Returns calculator for Dr. Reddy's Laboratories Limited (ADR) Stock including INR - Dollar returns

The Dr. Reddy's Laboratories Limited (ADR) stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Dr. Reddy's Laboratories Limited (ADR) investment value today

Current value as on today

₹94,301

Returns

-₹5,699

(-5.7%)

Returns from Dr. Reddy's Laboratories Limited (ADR) Stock

-₹13,271 (-13.27%)

Dollar Impact

₹7,572 (+7.57%)

Analyst Recommendation on Dr. Reddy's Laboratories Limited (ADR) Stock

Based on 40 analysts

BUY

42.50%

Buy

30.00%

Hold

27.50%

Sell

Based on 40 analysts, 42.5% of analysts recommend a 'BUY' rating for Dr. Reddy's Laboratories Limited (ADR). Average target price of $13.51

Dr. Reddy's Laboratories Limited (ADR) Share Price Target

Get share price movements and forecasts by analysts on Dr. Reddy's Laboratories Limited (ADR).

What analysts predicted

10.51%UPSIDE

Target Price

$13.51

Current Price

$12.09

Analyzed by

40 Analysts

Target

$13.51

Dr. Reddy's Laboratories Limited (ADR) target price $13.51, a slight upside of 10.51% compared to current price of $12.09. According to 40 analysts rating.

Indian Investors' Interest in Dr. Reddy's Laboratories Limited (ADR) Stock

Investment in Dr. Reddy's Laboratories Limited (ADR) Shares on INDmoney has grown by 275.94% in the last 30 days, indicating increased investment activity.

Time period: to

Change:275.94% versus previous 30 day period

Search interest for Dr. Reddy's Laboratories Limited (ADR) Stock has increased by 71% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:71% versus previous 30 day period

Dr. Reddy's Laboratories Limited (ADR) Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
852
919
956
983
983
85,452
88,051
87,268
76,331
81,183
Gross Profit
499
555
570
577
546
48,627
48,140
46,806
34,215
37,762
Operating Income
14,959
17,925
17,551
18,720
17,647
17,475
17,513
14,238
473
2,971
EBITDA
20,322
21,757
23,899
24,279
25,264
24,642
24,308
19,560
8,758
2,971
Interest Expense
593
598
757
818
656
830
907
951
1,073
1,262
Depreciation
3,713
3,810
3,975
4,719
4,554
4,765
5,051
5,213
5,559
5,372
Income Before Tax
16,016
18,821
19,167
18,742
20,054
19,047
18,350
15,429
2,021
5,558
Income Tax Expense
2,946
4,901
5,752
4,704
4,182
4,951
4,082
3,533
-217
1,184
Net Income
157
166
149
166
184
14,178
14,372
12,098
2,235
4,461
Net Profit Margin
18.45%
18.14%
15.66%
16.91%
18.74%
16.59%
16.32%
13.86%
2.93%
5.50%

Dr. Reddy's Laboratories Limited (ADR) Annual Profit & Loss

All numbers in Millions USD

Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Total Revenue
2,138
2,184
2,207
2,340
35
2,813
2,989
3,361
3,763
353,471
Gross Profit
1,189
1,173
1,196
1,260
17
1,493
1,694
1,970
2,201
186,518
Operating Income
13,498
11,917
20,888
15,993
431
29,476
57,144
67,729
71,843
48,867
EBITDA
24,775
23,627
35,522
41,785
534
45,080
74,431
88,422
96,671
83,293
Interest Expense
634
788
889
13
970
958
1,428
1,711
2,829
3,933
Depreciation
-
11,710
12,190
12,472
12,796
11,824
12,502
14,841
17,058
20,588
Income Before Tax
14,653
14,341
22,443
18,032
355
32,298
60,367
71,870
76,784
57,678
Income Tax Expense
2,614
4,535
3,648
-1,466
123
8,730
15,300
16,186
19,539
12,995
Net Income
182
150
269
261
3
309
548
670
653
45,087
Net Profit Margin
8.55%
6.90%
12.22%
11.17%
9.09%
10.99%
18.33%
19.95%
17.37%
12.76%

Dr. Reddy's Laboratories Limited (ADR) Quarterly Cash Flow

All numbers in Millions USD

Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
13,920
13,415
14,038
15,872
14,096
14,268
11,897
2,235
4,348
Operating Cash Flow
8,496
9,316
6,620
21,996
14,629
15,573
10,908
15,437
-927
Investing Cash Flow
-20,248
-19,071
-5,458
-13,300
-19,192
-9,543
-10,292
-28,222
3,836
Financing Cash Flow
9,541
16,150
590
-7,370
-1,203
-5,323
7,777
8,738
-7,117
Change in Cash
-2,194
6,372
1,747
1,561
-5,589
902
8,751
-4,234
-4,169

Dr. Reddy's Laboratories Limited (ADR) Annual Cash Flow

All numbers in Millions USD

Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Net Income
9,806
18,795
19,498
19,149
23,568
60,485
55,684
57,245
45,087
Operating Cash Flow
18,029
28,704
29,841
35,703
28,108
58,873
45,433
46,428
56,645
Investing Cash Flow
-14,883
-7,727
-4,923
-22,660
-26,387
-41,373
-40,283
-58,077
-70,533
Financing Cash Flow
-4,440
-21,326
-25,159
-298
-2,422
-26,861
-3,763
18,911
13,395
Change in Cash
-1,237
-314
-266
12,858
32
-9,073
1,328
7,486
-875

Global Institutional Holdings in Dr. Reddy's Laboratories Limited (ADR)

Funds
Holdings
Geode Capital Management, LLC
0.16%
UBS Group AG
0.19%
Lazard Asset Management LLC
0.14%
Royal Bank of Canada
1.2%
Northern Trust Corp
0.13%
See all

Dr. Reddy's Laboratories Limited (ADR) News & Key Events

    Insights on Dr. Reddy's Laboratories Limited (ADR)

    Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

    • imgPOSITIVE IMPACT

      Profit Spike

      img

      Netprofit is up for the last 2 quarters, 2.23B → 4.46B (in $), with an average increase of 49.9% per quarter

    • imgPOSITIVE IMPACT

      Revenue Rich

      img

      Revenue is up for the last 2 quarters, 76.33B → 81.18B (in $), with an average increase of 6.0% per quarter

    • imgNO EFFECT

      Against Peers

      img

      In the last 3 years, United Therapeutics Corporation Common Stock has given 68.0% return, outperforming this stock by 82.0%

    • imgNO EFFECT

      Against Peers

      img

      In the last 1 year, Viatris Inc. Common Stock has given 99.3% return, outperforming this stock by 114.3%

    • imgNEGATIVE IMPACT

      Price Dip

      img

      In the last 1 month, RDY stock has moved down by -17.6%

    About Dr. Reddy's Laboratories Limited (ADR)

    Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company North America, Europe, India, Russia, and internationally. The company operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Others segment. Its Global Generics segment manufactures and markets prescription and over-the-counter finished pharmaceutical products that are marketed under a brand name or as a generic finished dosages with therapeutic equivalence to branded formulations, as well as engages in the biologics business. The PSAI segment manufactures and markets active pharmaceutical ingredients and intermediates, which are principal ingredients for finished pharmaceutical products. This segment also provides contract research services; and manufactures and sells active pharmaceutical ingredients and steroids with the customer requirements. Its Others segment engages in developing therapies in the fields of oncology and inflammation; and research, development, and commercialization of differentiated formulations. The company offers its products for various therapeutic categories, including gastro-intestinal, cardiovascular, anti-diabetic, dermatology, oncology, respiratory, stomatology, urology, and nephrology, vaccines, vitamins and minerals, and pain management. Dr. Reddy's Laboratories Limited was incorporated in 1984 and is headquartered in Hyderabad, India.
    OrganisationDr. Reddy's Laboratories Limited (ADR)
    Headquarters8-2-337, Road No. 3, Hyderabad, India, 500034
    IndustryDrug Manufacturers - Specialty & Generic
    CEOMr. Erez Israeli M.B.A.
    E-voting on sharesClick here to vote

    Key Management of Dr. Reddy's Laboratories Limited (ADR)

    Name

    Title

    Mr. Kallam Satish Reddy B.Tech., M.S.

    Chairman of the Board & Member of the Management Council

    Mr. Motupalli Venkata Ramana M.B.A.

    CEO of Global Generics & Member of Management Council

    Mr. Sanjay Sharma B.Tech.

    Executive VP, COO & Member of Management Council

    Mr. Patrick Aghanian B.A., M.B.A.

    Head of Consumer Health Organization & Member of Management Council

    Mr. Bhethanabottla S. Phanimitra

    Chief Digital & Information Officer and Member of the Management Council

    Mr. Gunupati Venkateswara Prasad B.E.

    Co-Chairman, MD & Member of Management Council

    Mr. Erez Israeli M.B.A.

    CEO & Member of the Management Council

    Mr. Mannam Venkatanarasimham

    CFO & Member of the Management Council

    Mr. Krishna K. Venkatesh B.Pharma M.S.

    Global Head of IPDO, Integrated Product Development & Member of the Management Council

    Mr. Deepak Sapra M.B.A.

    Global Head of Pharmaceutical Services and Active Ingredients & Member of Management Council

    FAQs

    What is Dr. Reddy's Laboratories Limited (ADR) share price today?

    Dr. Reddy's Laboratories Limited (ADR) share price today is $12.09 as on . Dr. Reddy's Laboratories Limited (ADR) share today touched a day high of $12.14 and a low of $11.97.

    What is the 52 week high and 52 week low for Dr. Reddy's Laboratories Limited (ADR) share?

    Dr. Reddy's Laboratories Limited (ADR) share touched a 52 week high of $15.67 on and a 52 week low of $11.36 on . Dr. Reddy's Laboratories Limited (ADR) stock price today i.e. is trending at $12.09,which is 22.85% down from its 52 week high and 6.43% up from its 52 week low.

    What is Dr. Reddy's Laboratories Limited (ADR)'s market capitalisation today?

    Dr. Reddy's Laboratories Limited (ADR) market capitalisation is $0.01T as on .

    How to invest in Dr. Reddy's Laboratories Limited (ADR) Stock (RDY) from India?

    1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
    2. Step 2: Search for Dr. Reddy's Laboratories Limited (ADR) on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Dr. Reddy's Laboratories Limited (ADR) Shares that will get you 0.1241 shares as per Dr. Reddy's Laboratories Limited (ADR) share price of $12.09 per share as on August 3, 2026 at 7:43 pm IST.

    What is the minimum amount required to buy Dr. Reddy's Laboratories Limited (ADR) Stock (RDY) from India?

    Indian investors can start investing in Dr. Reddy's Laboratories Limited (ADR) (RDY) shares with as little as ₹95.335 or $1 (as of ) using the INDmoney app.
    For example: If you want to invest $10 or ₹953.35 in Dr. Reddy's Laboratories Limited (ADR) stock (as per the Rupee-Dollar exchange rate as on ). Based on Dr. Reddy's Laboratories Limited (ADR) share’s latest price of $12.09 as on August 3, 2026 at 7:43 pm IST, you will get 0.8271 shares of Dr. Reddy's Laboratories Limited (ADR). Learn more about fractional shares .

    What are the returns that Dr. Reddy's Laboratories Limited (ADR) has given to Indian investors in the last 5 years?

    Dr. Reddy's Laboratories Limited (ADR) stock has given -6.38% share price returns and 28.47% dollar appreciation to an Indian investor in the last 5 years.
    Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?